HER2-Positive Metastatic Breast Cancer: A Comprehensive Review

Abstract: Cases of human epidermal growth factor receptor 2 (HER2)–positive breast cancer represent approximately 15% to 20% of all breast cancers. Historically, this subtype of breast […]

How We Treat Locally Advanced HER2-Positive Breast Cancer

Overview • Neoadjuvant therapy should be the first choice in patients with HER2-positive locally advanced breast cancer. • Pertuzumab should be added to trastuzumab and […]